Insulet Revenue 2010-2024 | PODD
Insulet annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Insulet revenue for the quarter ending March 31, 2024 was $0.442B, a 23.35% increase year-over-year.
- Insulet revenue for the twelve months ending March 31, 2024 was $1.781B, a 30.17% increase year-over-year.
- Insulet annual revenue for 2023 was $1.697B, a 30.02% increase from 2022.
- Insulet annual revenue for 2022 was $1.305B, a 18.79% increase from 2021.
- Insulet annual revenue for 2021 was $1.099B, a 21.49% increase from 2020.
| Insulet Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,697 |
| 2022 | $1,305 |
| 2021 | $1,099 |
| 2020 | $904 |
| 2019 | $738 |
| 2018 | $564 |
| 2017 | $464 |
| 2016 | $367 |
| 2015 | $264 |
| 2014 | $231 |
| 2013 | $247 |
| 2012 | $211 |
| 2011 | $152 |
| 2010 | $97 |
| 2009 | $66 |
| Insulet Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $442 |
| 2023-12-31 | $510 |
| 2023-09-30 | $433 |
| 2023-06-30 | $397 |
| 2023-03-31 | $358 |
| 2022-12-31 | $370 |
| 2022-09-30 | $341 |
| 2022-06-30 | $299 |
| 2022-03-31 | $295 |
| 2021-12-31 | $308 |
| 2021-09-30 | $276 |
| 2021-06-30 | $263 |
| 2021-03-31 | $252 |
| 2020-12-31 | $246 |
| 2020-09-30 | $234 |
| 2020-06-30 | $226 |
| 2020-03-31 | $198 |
| 2019-12-31 | $209 |
| 2019-09-30 | $192 |
| 2019-06-30 | $177 |
| 2019-03-31 | $160 |
| 2018-12-31 | $165 |
| 2018-09-30 | $151 |
| 2018-06-30 | $124 |
| 2018-03-31 | $124 |
| 2017-12-31 | $131 |
| 2017-09-30 | $122 |
| 2017-06-30 | $110 |
| 2017-03-31 | $102 |
| 2016-12-31 | $104 |
| 2016-09-30 | $95 |
| 2016-06-30 | $87 |
| 2016-03-31 | $81 |
| 2015-12-31 | $84 |
| 2015-09-30 | $71 |
| 2015-06-30 | $61 |
| 2015-03-31 | $48 |
| 2014-12-31 | $15 |
| 2014-09-30 | $75 |
| 2014-06-30 | $72 |
| 2014-03-31 | $69 |
| 2013-12-31 | $69 |
| 2013-09-30 | $61 |
| 2013-06-30 | $60 |
| 2013-03-31 | $57 |
| 2012-12-31 | $58 |
| 2012-09-30 | $55 |
| 2012-06-30 | $51 |
| 2012-03-31 | $48 |
| 2011-12-31 | $47 |
| 2011-09-30 | $45 |
| 2011-06-30 | $32 |
| 2011-03-31 | $28 |
| 2010-12-31 | $28 |
| 2010-09-30 | $25 |
| 2010-06-30 | $23 |
| 2010-03-31 | $21 |
| 2009-12-31 | $20 |
| 2009-09-30 | $19 |
| 2009-06-30 | $15 |
| 2009-03-31 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.811B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.530B | 23.51 |
| Stryker (SYK) | United States | $127.352B | 30.50 |
| Boston Scientific (BSX) | United States | $112.306B | 35.77 |
| Medtronic (MDT) | Ireland | $99.209B | 14.85 |
| EssilorLuxottica (ESLOY) | France | $98.424B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.079B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
| ResMed (RMD) | United States | $27.817B | 26.12 |
| Terumo (TRUMY) | Japan | $24.149B | 34.10 |
| Koninklijke Philips (PHG) | Netherlands | $22.914B | 18.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.863B | 13.97 |
| Baxter (BAX) | United States | $16.740B | 11.90 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.789B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.686B | 36.15 |
| Bio-Rad Laboratories (BIO) | United States | $7.632B | 24.96 |
| Lantheus Holdings (LNTH) | United States | $5.441B | 13.56 |
| Haemonetics (HAE) | United States | $4.232B | 20.87 |
| GN Store Nord (GNNDY) | Denmark | $4.129B | 23.18 |
| Perrigo (PRGO) | Ireland | $3.543B | 10.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.408B | 16.22 |
| Neogen (NEOG) | United States | $3.277B | 31.52 |
| ICU Medical (ICUI) | United States | $2.864B | 25.27 |
| TG Therapeutics (TGTX) | United States | $2.830B | 79.61 |
| Envista Holdings (NVST) | United States | $2.808B | 11.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.387B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.363B | 46.25 |
| QuidelOrtho (QDEL) | United States | $2.100B | 11.66 |
| LeMaitre Vascular (LMAT) | United States | $1.822B | 53.41 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.723B | 0.00 |
| Warby Parker (WRBY) | United States | $1.589B | 0.00 |
| InMode (INMD) | Israel | $1.462B | 7.77 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| Verano Holdings (VRNOF) | United States | $1.228B | 0.00 |
| AtriCure (ATRC) | United States | $1.065B | 0.00 |
| Owens & Minor (OMI) | United States | $1.013B | 8.83 |
| National Vision Holdings (EYE) | United States | $0.980B | 31.20 |
| BioLife Solutions (BLFS) | United States | $0.932B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.40 |
| PetIQ (PETQ) | United States | $0.672B | 21.72 |
| Evolus (EOLS) | United States | $0.667B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.596B | 14.02 |
| Valneva SE (VALN) | France | $0.505B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.19 |
| Quanterix (QTRX) | United States | $0.487B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.477B | 0.00 |
| Biote (BTMD) | United States | $0.475B | 10.93 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.302B | 9.71 |
| Zynex (ZYXI) | United States | $0.288B | 39.44 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.233B | 14.69 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.213B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 21.96 |
| Capricor Therapeutics (CAPR) | United States | $0.151B | 0.00 |
| Veru (VERU) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.19 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.093B | 15.77 |
| Cellectar Biosciences (CLRB) | United States | $0.085B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.43 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.52 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |